{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:07:13Z","timestamp":1790096833830,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002002"],"award-info":[{"award-number":["KL2TR002002"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10549-020-05922-w","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T17:02:58Z","timestamp":1599843778000},"page":"195-204","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7744-3518","authenticated-orcid":false,"given":"Gregory S.","family":"Calip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Bernhisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah C.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Saam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth H.","family":"Rauscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan M.","family":"Lancaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent F.","family":"Hoskins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"5922_CR1","unstructured":"American Cancer Society Breast Cancer Facts & Figures 2019\u20132020. Atlanta: American Cancer Society, Inc. 2019."},{"issue":"1","key":"5922_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1023\/B:BREA.0000010701.08825.2d","volume":"83","author":"WF Anderson","year":"2004","unstructured":"Anderson WF, Althuis MD, Brinton LA, Devesa SS (2004) Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83(1):77\u201386. https:\/\/doi.org\/10.1023\/B:BREA.0000010701.08825.2d","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"5922_CR3","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/annonc\/mdt025","volume":"24","author":"KJ Ruddy","year":"2013","unstructured":"Ruddy KJ, Winer EP (2013) Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship. Ann Oncol 24(6):1434\u20131443. https:\/\/doi.org\/10.1093\/annonc\/mdt025","journal-title":"Ann Oncol"},{"issue":"1","key":"5922_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-015-0487-4","volume":"18","author":"RM Ferzoco","year":"2016","unstructured":"Ferzoco RM, Ruddy KJ (2016) The epidemiology of male breast cancer. Curr Oncol Rep 18(1):1. https:\/\/doi.org\/10.1007\/s11912-015-0487-4","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"5922_CR5","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/0003-4819-137-8-200210150-00013","volume":"137","author":"SH Giordano","year":"2002","unstructured":"Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Intern Med 137(8):678\u2013687","journal-title":"Ann Intern Med"},{"issue":"20","key":"5922_CR6","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/jnci\/djn329","volume":"100","author":"LA Brinton","year":"2008","unstructured":"Brinton LA, Richesson DA, Gierach GL, Lacey JV Jr, Park Y, Hollenbeck AR, Schatzkin A (2008) Prospective evaluation of risk factors for male breast cancer. J Natl Cancer Inst 100(20):1477\u20131481. https:\/\/doi.org\/10.1093\/jnci\/djn329","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"5922_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1093\/jnci\/83.12.849","volume":"83","author":"KA Rosenblatt","year":"1991","unstructured":"Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, Thompson WD, Curnen MG, Satariano W, Austin DF et al (1991) Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst 83(12):849\u2013854","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"5922_CR8","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/jmg.2009.075176","volume":"47","author":"DG Evans","year":"2010","unstructured":"Evans DG, Susnerwala I, Dawson J, Woodward E, Maher ER, Lalloo F (2010) Risk of breast cancer in male BRCA2 carriers. J Med Genet 47(10):710\u2013711. https:\/\/doi.org\/10.1136\/jmg.2009.075176","journal-title":"J Med Genet"},{"issue":"23","key":"5922_CR9","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/jnci\/djm203","volume":"99","author":"YC Tai","year":"2007","unstructured":"Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811\u20131814. https:\/\/doi.org\/10.1093\/jnci\/djm203","journal-title":"J Natl Cancer Inst"},{"issue":"6559","key":"5922_CR10","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378(6559):789\u2013792. https:\/\/doi.org\/10.1038\/378789a0","journal-title":"Nature"},{"issue":"1","key":"5922_CR11","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/bcr419","volume":"4","author":"VM Basham","year":"2002","unstructured":"Basham VM, Lipscombe JM, Ward JM, Gayther SA, Ponder BA, Easton DF, Pharoah PD (2002) BRCA1 and BRCA2 mutations in a population-based study of male breast cancer. Breast Cancer Res 4(1):R2","journal-title":"Breast Cancer Res"},{"issue":"1","key":"5922_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ng0596-123","volume":"13","author":"FJ Couch","year":"1996","unstructured":"Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13(1):123\u2013125. https:\/\/doi.org\/10.1038\/ng0596-123","journal-title":"Nat Genet"},{"issue":"23","key":"5922_CR13","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario Canada. J Natl Cancer Inst 98(23):1694\u20131706. https:\/\/doi.org\/10.1093\/jnci\/djj465","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"5922_CR14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333. https:\/\/doi.org\/10.1200\/JCO.2006.09.1066","journal-title":"J Clin Oncol"},{"issue":"5","key":"5922_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjakoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130. https:\/\/doi.org\/10.1086\/375033","journal-title":"Am J Hum Genet"},{"issue":"2","key":"5922_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-008-0162-7","volume":"116","author":"M Wasielewski","year":"2009","unstructured":"Wasielewski M, den Bakker MA, van den Ouweland A, Meijer-van Gelder ME, Portengen H, Klijn JG, Meijers-Heijboer H, Foekens JA, Schutte M (1100delC) CHEK2 1100delC and male breast cancer in the Netherlands. Breast Cancer Res Treat 116(2):397\u2013400. https:\/\/doi.org\/10.1007\/s10549-008-0162-7","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"5922_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng879","volume":"31","author":"Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR, Consortium CH-BC","year":"2002","unstructured":"Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton D, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber B, Rahman N, Stratton MR, Consortium CH-BC (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31(1):55\u201359. https:\/\/doi.org\/10.1038\/ng879","journal-title":"Nat Genet"},{"issue":"2","key":"5922_CR18","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10549-010-1289-x","volume":"126","author":"V Silvestri","year":"2011","unstructured":"Silvestri V, Rizzolo P, Falchetti M, Zanna I, Masala G, Bianchi S, Palli D, Ottini L (2011) Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy. Breast Cancer Res Treat 126(2):539\u2013543. https:\/\/doi.org\/10.1007\/s10549-010-1289-x","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5922_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/cncr.30337","volume":"123","author":"V Silvestri","year":"2017","unstructured":"Silvestri V, Zelli V, Valentini V, Rizzolo P, Navazio AS, Coppa A, Agata S, Oliani C, Barana D, Castrignano T, Viel A, Russo A, Tibiletti MG, Zanna I, Masala G, Cortesi L, Manoukian S, Azzollini J, Peissel B, Bonanni B, Peterlongo P, Radice P, Palli D, Giannini G, Chillemi G, Montagna M, Ottini L (2017) Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene. Cancer 123(2):210\u2013218. https:\/\/doi.org\/10.1002\/cncr.30337","journal-title":"Cancer"},{"issue":"1","key":"5922_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10549-010-0797-z","volume":"122","author":"V Silvestri","year":"2010","unstructured":"Silvestri V, Rizzolo P, Zanna I, Falchetti M, Masala G, Bianchi S, Papi L, Giannini G, Palli D, Ottini L (2010) PALB2 mutations in male breast cancer: a population-based study in Central Italy. Breast Cancer Res Treat 122(1):299\u2013301. https:\/\/doi.org\/10.1007\/s10549-010-0797-z","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5922_CR21","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10549-010-1195-2","volume":"126","author":"YC Ding","year":"2011","unstructured":"Ding YC, Steele L, Kuan CJ, Greilac S, Neuhausen SL (2011) Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States. Breast Cancer Res Treat 126(3):771\u2013778. https:\/\/doi.org\/10.1007\/s10549-010-1195-2","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5922_CR22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ijc.11384","volume":"108","author":"K Syrjakoski","year":"2004","unstructured":"Syrjakoski K, Kuukasjarvi T, Auvinen A, Kallioniemi OP (1100delC) CHEK2 1100delC is not a risk factor for male breast cancer population. Int J Cancer 108(3):475\u2013476. https:\/\/doi.org\/10.1002\/ijc.11384","journal-title":"Int J Cancer"},{"issue":"1","key":"5922_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10549-007-9689-2","volume":"110","author":"M Falchetti","year":"2008","unstructured":"Falchetti M, Lupi R, Rizzolo P, Ceccarelli K, Zanna I, Calo V, Tommasi S, Masala G, Paradiso A, Gulino A, Giannini G, Russo A, Palli D, Ottini L (2008) BRCA1\/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases. Breast Cancer Res Treat 110(1):161\u2013167. https:\/\/doi.org\/10.1007\/s10549-007-9689-2","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"5922_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cancergen.2015.02.006","volume":"208","author":"P Apostolou","year":"2015","unstructured":"Apostolou P, Fostira F, Papamentzelopoulou M, Michelli M, Panopoulos C, Fountzilas G, Konstantopoulou I, Voutsinas GE, Yannoukakos D (2015) CHEK2 c.1100delC allele is rarely identified in Greek breast cancer cases. Cancer Genet 208(4):129\u2013134. https:\/\/doi.org\/10.1016\/j.cancergen.2015.02.006","journal-title":"Cancer Genet"},{"issue":"3","key":"5922_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ijc.11385","volume":"108","author":"S Neuhausen","year":"2004","unstructured":"Neuhausen S, Dunning A, Steele L, Yakumo K, Hoffman M, Szabo C, Tee L, Baines C, Pharoah P, Goldgar D, Easton D (2004) Role of CHEK2*1100delC in unselected series of non-BRCA1\/2 male breast cancers. Int J Cancer 108(3):477\u2013478. https:\/\/doi.org\/10.1002\/ijc.11385","journal-title":"Int J Cancer"},{"issue":"3","key":"5922_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10549-016-4085-4","volume":"161","author":"M Pritzlaff","year":"2017","unstructured":"Pritzlaff M, Summerour P, McFarland R, Li S, Reineke P, Dolinsky JS, Goldgar DE, Shimelis H, Couch FJ, Chao EC, LaDuca H (2017) Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results. Breast Cancer Res Treat 161(3):575\u2013586. https:\/\/doi.org\/10.1007\/s10549-016-4085-4","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"5922_CR27","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/jnci\/djt095","volume":"105","author":"N Mavaddat","year":"2013","unstructured":"Mavaddat N, Peock S, Frost D, Ellis S, Platte R, Fineberg E, Evans DG, Izatt L, Eeles RA, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Douglas F, Hodgson S, Walker L, Porteous ME, Morrison PJ, Side LE, Kennedy MJ, Houghton C, Donaldson A, Rogers MT, Dorkins H, Miedzybrodzka Z, Gregory H, Eason J, Barwell J, McCann E, Murray A, Antoniou AC, Easton DF, Embrace (2013) Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. J Natl Cancer Inst 105(11):812\u2013822. https:\/\/doi.org\/10.1093\/jnci\/djt095","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"5922_CR28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/jnci\/94.18.1365","volume":"94","author":"MS Brose","year":"2002","unstructured":"Brose MS, Rebbeck TR, Calzone KA, Stopfer JE, Nathanson KL, Weber BL (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94(18):1365\u20131372","journal-title":"J Natl Cancer Inst"},{"issue":"14","key":"5922_CR29","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/jnci\/84.14.1114","volume":"84","author":"DE Anderson","year":"1992","unstructured":"Anderson DE, Badzioch MD (1992) Breast cancer risks in relatives of male breast cancer patients. J Natl Cancer Inst 84(14):1114\u20131117","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"5922_CR30","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s10549-011-1915-2","volume":"132","author":"M Bevier","year":"2012","unstructured":"Bevier M, Sundquist K, Hemminki K (2012) Risk of breast cancer in families of multiple affected women and men. Breast Cancer Res Treat 132(2):723\u2013728. https:\/\/doi.org\/10.1007\/s10549-011-1915-2","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"5922_CR31","first-page":"313","volume":"60","author":"LS Friedman","year":"1997","unstructured":"Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, Ponder BA, Anton-Culver H (1997) Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet 60(2):313\u2013319","journal-title":"Am J Hum Genet"},{"issue":"4","key":"5922_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2008) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u2013349. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"issue":"9304","key":"5922_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S0140-6736(02)07605-5","volume":"359","author":"KF Schulz","year":"2002","unstructured":"Schulz KF, Grimes DA (2002) Case-control studies: research in reverse. Lancet 359(9304):431\u2013434","journal-title":"Lancet"},{"issue":"3","key":"5922_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/cge.12315","volume":"86","author":"JM Eggington","year":"2014","unstructured":"Eggington JM, Bowles KR, Moyes K, Manley S, Esterling L, Sizemore S, Rosenthal E, Theisen A, Saam J, Arnell C, Pruss D, Bennett J, Burbidge LA, Roa B, Wenstrup RJ (2014) A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes. Clin Genet 86(3):229\u2013237. https:\/\/doi.org\/10.1111\/cge.12315","journal-title":"Clin Genet"},{"issue":"9148","key":"5922_CR35","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0140-6736(05)77219-6","volume":"353","author":"HH Storm","year":"1999","unstructured":"Storm HH, Olsen J (1999) Risk of breast cancer in offspring of male breast-cancer patients. Lancet 353(9148):209. https:\/\/doi.org\/10.1016\/S0140-6736(05)77219-6","journal-title":"Lancet"},{"issue":"16","key":"5922_CR36","doi-asserted-by":"publisher","first-page":"8297","DOI":"10.1158\/0008-5472.CAN-06-0503","volume":"66","author":"KE Malone","year":"2006","unstructured":"Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66(16):8297\u20138308","journal-title":"Cancer Res"},{"key":"5922_CR37","doi-asserted-by":"publisher","DOI":"10.2202\/1557-4679.1127","author":"S Rose","year":"2009","unstructured":"Rose S, Laan MJ (2009) Why match? Investigating matched case-control study designs with causal effect estimation. Int J Biostat. https:\/\/doi.org\/10.2202\/1557-4679.1127","journal-title":"Int J Biostat"},{"issue":"3","key":"5922_CR38","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/oxfordjournals.aje.a009259","volume":"146","author":"RA Kerber","year":"1997","unstructured":"Kerber RA, Slattery ML (1997) Comparison of self-reported and database-linked family history of cancer data in a case-control study. Am J Epidemiol 146(3):244\u2013248","journal-title":"Am J Epidemiol"},{"issue":"9","key":"5922_CR39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.gim.0000237867.34011.12","volume":"8","author":"SD Ramsey","year":"2006","unstructured":"Ramsey SD, Yoon P, Moonesinghe R, Khoury MJ (2006) Population-based study of the prevalence of family history of cancer: implications for cancer screening and prevention. Genet Med 8(9):571\u2013575. https:\/\/doi.org\/10.1097\/01.gim.0000237867.34011.12","journal-title":"Genet Med"},{"issue":"4","key":"5922_CR40","doi-asserted-by":"publisher","first-page":"380","DOI":"10.6004\/jnccn.2020.0017","volume":"18","author":"MB Daly","year":"2020","unstructured":"Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, Kurian AW, Laronga C, Litton JK, Mak JS, Menendez CS, Merajver SD, Norquist BS, Offit K, Pal T, Pederson HJ, Reiser G, Shannon KM, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Dwyer MA, Darlow SD (2020) NCCN guidelines insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020. J Natl Compr Cancer Netw 18(4):380\u2013391. https:\/\/doi.org\/10.6004\/jnccn.2020.0017","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"5922_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/00008469-200206000-00009","volume":"11","author":"Johnson KC, Pan S, Mao Y, Canadian Cancer Registries Epidemiology Research G","year":"2002","unstructured":"Johnson KC, Pan S, Mao Y, Canadian Cancer Registries Epidemiology Research G (2002) Risk factors for male breast cancer in Canada, 1994\u20131998. Eur J Cancer 11(3):253\u2013263. https:\/\/doi.org\/10.1097\/00008469-200206000-00009","journal-title":"Eur J Cancer"},{"issue":"4","key":"5922_CR42","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/028418601750288181","volume":"40","author":"M Ewertz","year":"2001","unstructured":"Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A (2001) Risk factors for male breast cancer\u2014a case-control study from Scandinavia. Acta Oncol 40(4):467\u2013471. https:\/\/doi.org\/10.1080\/028418601750288181","journal-title":"Acta Oncol"},{"key":"5922_CR43","volume-title":"Modern epidemiology","author":"KJ Rothman","year":"2008","unstructured":"Rothman KJ, Greenland S, Lash TL (2008) Modern epidemiology, 3rd edn. Wolters Kluwer Health\/Lippincott Williams & Wilkins, Philadelphia","edition":"3"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05922-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05922-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T23:50:34Z","timestamp":1631317834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05922-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["5922"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05922-w","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mr. Kidd, Mr. Bernhisel, Dr. Cox, Mr. Evans, Dr. Saam and Dr. Lancaster received salary support and have ownership interest (stock options) in Myriad Genetics Laboratories, Inc. At the time of submission, Dr. Calip reports current employment with Flatiron Health, Inc., which is an independent subsidiary of the Roche group. Dr. Calip and Dr. Hoskins report receiving research support from Pfizer, Inc. for work unrelated to this project. Dr. Rauscher declares he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The University of Illinois at Chicago Institutional Review Board (IRB), Chicago, IL approved the study (IRB Protocol # 2015\u20131176). The need for informed consent was waived under the approval of the IRB due to the retrospective design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}